| Product Code: ETC066681 | Publication Date: Aug 2021 | Updated Date: Jun 2026 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The Brazil Infectious Disease Point-of-care Testing Market was estimated at USD 161 Million in 2025 and is projected to reach USD 192 Million by 2032, growing at a CAGR of 2.5% from 2026 to 2032. This growth is largely fueled by the expanding healthcare infrastructure and enhanced disease management strategies within Brazil. The increasing incidence of infectious diseases, coupled with a growing awareness of the importance of timely diagnostics, is propelling the demand for innovative point-of-care testing solutions.
This graph highlights how the Brazil Infectious Disease Point-of-care Testing Market has steadily grown over the years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | -1.7% | Increasing industrial infrastructure investments |
| 2022 | 5.4% | Government infrastructure modernization initiatives |
| 2023 | 4.0% | Expansion of commercial construction activities |
| 2024 | 4.1% | Increasing industrial automation investments |
| 2025 | 4.2% | Increasing industrial infrastructure investments |
| 2026 | 2.6% | Government infrastructure modernization initiatives |
| 2027 | 3.0% | Increasing adoption of advanced technologies |
| 2028 | 3.0% | Government infrastructure modernization initiatives |
| 2029 | 3.2% | Growing renewable energy integration projects |
| 2030 | 3.1% | Rising electricity demand across industries |
| 2031 | 3.1% | Growing renewable energy integration projects |
| 2032 | 2.8% | Increasing industrial automation investments |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch’s advanced forecasting approach, validated with industry datasets as of June 2026.
The Brazilian market for infectious disease point-of-care testing has witnessed a remarkable increase in demand, particularly for tests detecting HIV, malaria, and tuberculosis. Rapid diagnostic tests that can deliver results within minutes are becoming integral to both urban and rural healthcare settings, enhancing patient outcomes and streamlining clinical workflows.
A significant shift towards integrated healthcare solutions is also noted, where point-of-care testing is being incorporated into community health programs. This integration supports epidemiological surveillance and bolsters public health initiatives aimed at curbing disease outbreaks throughout the country.
Despite the promising growth trajectory, the Brazil Infectious Disease Point-of-care Testing Market faces several restraints. Regulatory hurdles for diagnostic devices and assays can lead to delays in product approvals, hindering timely market entry. Additionally, ensuring quality assurance in testing solutions poses challenges, particularly when striving for rapidity without compromising accuracy. Competition from imported kits and alternative diagnostic methods may also pressure local manufacturers, affecting market pricing strategies and overall penetration.
The market is currently trending towards the adoption of digital health technologies, including telemedicine and mobile health applications. These technologies complement point-of-care testing by facilitating remote patient management and consultation. Furthermore, there is a noticeable increase in the development of multi-disease testing kits, allowing healthcare providers to diagnose multiple conditions simultaneously, thereby optimizing resource allocation and enhancing diagnostic efficiency.
Significant growth opportunities exist in Brazil's underserved and remote regions where access to healthcare facilities is limited. Developing point-of-care testing solutions tailored to these areas can catalyze early disease detection and management. Additionally, partnerships with local healthcare providers can lead to customized approaches that address specific regional needs, ultimately improving health outcomes and market penetration.
Brazilian government initiatives focus on enhancing public health surveillance and improving access to healthcare. Policies regulating point-of-care testing devices ensure safety and reliability in disease detection. Funding is increasingly directed toward research and development of innovative diagnostic technologies, particularly for infectious diseases like COVID-19, Zika virus, and dengue fever. Moreover, initiatives to integrate point-of-care testing into community health services illustrate the commitment to bolstering public health infrastructure.
Looking ahead to 2026-2032, the Brazil Infectious Disease Point-of-care Testing Market is poised for transformative changes driven by technological advancements and increased health awareness. The focus will likely shift towards developing sophisticated testing solutions that are both user-friendly and capable of providing results with high accuracy. As Brazil continues to prioritize healthcare accessibility, innovations that integrate point-of-care testing into everyday clinical practice will be essential for tackling infectious diseases effectively.
Recent developments in the market indicate a rising inclination towards the automation of point-of-care testing processes. Companies are exploring partnerships to enhance the distribution networks, ensuring rapid availability of diagnostic tools across various regions. Furthermore, the government’s focus on public-private partnerships is expected to spur advancements in point-of-care technologies, specifically targeting hard-to-reach populations.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Brazil Infectious Disease Point-of-care Testing Market Overview |
3.1 Brazil Country Macro Economic Indicators |
3.2 Brazil Infectious Disease Point-of-care Testing Market Revenues & Volume, 2022 & 2032F |
3.3 Brazil Infectious Disease Point-of-care Testing Market - Industry Life Cycle |
3.4 Brazil Infectious Disease Point-of-care Testing Market - Porter's Five Forces |
3.5 Brazil Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By Applications, 2022 & 2032F |
3.6 Brazil Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By Technologies, 2022 & 2032F |
3.7 Brazil Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By End-users, 2022 & 2032F |
4 Brazil Infectious Disease Point-of-care Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Brazil |
4.2.2 Rising awareness about the benefits of point-of-care testing for infectious diseases |
4.2.3 Technological advancements in point-of-care testing devices |
4.3 Market Restraints |
4.3.1 Lack of skilled healthcare professionals for conducting point-of-care tests |
4.3.2 High cost associated with point-of-care testing devices and consumables |
5 Brazil Infectious Disease Point-of-care Testing Market Trends |
6 Brazil Infectious Disease Point-of-care Testing Market, By Types |
6.1 Brazil Infectious Disease Point-of-care Testing Market, By Applications |
6.1.1 Overview and Analysis |
6.1.2 Brazil Infectious Disease Point-of-care Testing Market Revenues & Volume, By Applications, 2022-2032F |
6.1.3 Brazil Infectious Disease Point-of-care Testing Market Revenues & Volume, By Tropical Disease, 2022-2032F |
6.1.4 Brazil Infectious Disease Point-of-care Testing Market Revenues & Volume, By Liver Disease, 2022-2032F |
6.1.5 Brazil Infectious Disease Point-of-care Testing Market Revenues & Volume, By Respiratory Disease, 2022-2032F |
6.1.6 Brazil Infectious Disease Point-of-care Testing Market Revenues & Volume, By Sexual Disorders, 2022-2032F |
6.1.7 Brazil Infectious Disease Point-of-care Testing Market Revenues & Volume, By Others, 2022-2032F |
6.2 Brazil Infectious Disease Point-of-care Testing Market, By Technologies |
6.2.1 Overview and Analysis |
6.2.2 Brazil Infectious Disease Point-of-care Testing Market Revenues & Volume, By Lateral Flow, 2022-2032F |
6.2.3 Brazil Infectious Disease Point-of-care Testing Market Revenues & Volume, By Flow-through, 2022-2032F |
6.2.4 Brazil Infectious Disease Point-of-care Testing Market Revenues & Volume, By Agglutination Assays, 2022-2032F |
6.2.5 Brazil Infectious Disease Point-of-care Testing Market Revenues & Volume, By Solid Phase, 2022-2032F |
6.3 Brazil Infectious Disease Point-of-care Testing Market, By End-users |
6.3.1 Overview and Analysis |
6.3.2 Brazil Infectious Disease Point-of-care Testing Market Revenues & Volume, By Diagnostic Laboratories, 2022-2032F |
6.3.3 Brazil Infectious Disease Point-of-care Testing Market Revenues & Volume, By Hospitals, 2022-2032F |
6.3.4 Brazil Infectious Disease Point-of-care Testing Market Revenues & Volume, By Home-care Settings, 2022-2032F |
6.3.5 Brazil Infectious Disease Point-of-care Testing Market Revenues & Volume, By Others, 2022-2032F |
7 Brazil Infectious Disease Point-of-care Testing Market Import-Export Trade Statistics |
7.1 Brazil Infectious Disease Point-of-care Testing Market Export to Major Countries |
7.2 Brazil Infectious Disease Point-of-care Testing Market Imports from Major Countries |
8 Brazil Infectious Disease Point-of-care Testing Market Key Performance Indicators |
8.1 Average turnaround time for point-of-care test results |
8.2 Number of healthcare facilities offering point-of-care testing services |
8.3 Rate of adoption of point-of-care testing technology by healthcare providers |
9 Brazil Infectious Disease Point-of-care Testing Market - Opportunity Assessment |
9.1 Brazil Infectious Disease Point-of-care Testing Market Opportunity Assessment, By Applications, 2022 & 2032F |
9.2 Brazil Infectious Disease Point-of-care Testing Market Opportunity Assessment, By Technologies, 2022 & 2032F |
9.3 Brazil Infectious Disease Point-of-care Testing Market Opportunity Assessment, By End-users, 2022 & 2032F |
10 Brazil Infectious Disease Point-of-care Testing Market - Competitive Landscape |
10.1 Brazil Infectious Disease Point-of-care Testing Market Revenue Share, By Companies, 2025 |
10.2 Brazil Infectious Disease Point-of-care Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here